Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX
Fust Matthew K received 5,925 Crinetics Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Jun 18, 2026 · Filed Jun 22, 2026
On Jun 18, 2026, Fust Matthew K (Director) received 5,925 Crinetics Pharmaceuticals, Inc. shares as an award, leaving 28,761 shares. Filed Jun 22, 2026 (Form 4).
- Awarded
- 5,925 shares
- Holding after
- 28,761 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Common Stock | Award | 5,925 | 28,761 | Direct |
Source
Related
- Crinetics Pharmaceuticals, Inc.
- Fust Matthew K
- Crinetics Pharmaceuticals, Inc. shareholders
- Form 4 · Fust Matthew K · Sep 1, 2026
- Form 4 · Wierenga Wendell · Sep 1, 2026
- Form 4 · Vivaldi Coelho Rogerio · Sep 1, 2026
- Form 4 · Okey Stephanie · Sep 1, 2026
- Form 4 · Nichols Weston · Sep 1, 2026
- Form 4 · Deardorf Caren · Sep 1, 2026